Bactericidal Kinetics of 3 Lactoferricins Against Staphylococcus aureus and Escherichia coli

References

• Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995; 58: 128–36.
   Google Scholar
• Hultmark D, Steiner H, Rasmuson T, Boman HG. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem 1980; 106: 7–16.
   Google Scholar
• Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993; 61: 2978–84.
   Google Scholar
• Christensen B, Fink J, Merrifield RB, Mauzerall D. Channelforming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci USA 1988; 85: 5072–6.
   PubMed Web of Science ®Google Scholar
• Duclohier H. Anion pores from magainins and related defensive peptides. Toxicology 1994; 87: 175–88.
   PubMed Web of Science ®Google Scholar
• Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990; 87: 210–4.
   PubMed Web of Science ®Google Scholar
• Blondelle SE, Perez-Paya E, Houghten RA. Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents. Antimicrob Agents Chemother 1996; 40: 1067–71.
   PubMed Web of Science ®Google Scholar
• Fink J, Merrifield RB, Boman A, Boman HG. The chemical synthesis of cecropin D and an analog with enhanced antibacterial activity. J Biol Chem 1989; 264: 6260–7.
   PubMed Web of Science ®Google Scholar
• Iwahori A, Hirota Y, Sampe R, Miyano S, Numao N. Synthesis of reversed magainin 2 analogs enhanced antibacterial activity. Biol Pharm Bull 1997; 20: 267–70.
   Google Scholar
• Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 1991; 74: 4137–42.
   PubMed Web of Science ®Google Scholar
• Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1992; 1121: 130–6.
   PubMed Web of Science ®Google Scholar
• Hwang PM, Zhou N, Shan X, Arrowsmith CH, Vogel HJ. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 1998; 37: 4288–98.
   Google Scholar
• Bellamy WR, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 1992; 73: 472–9.
   Google Scholar
• Bellamy WR, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol (Berl) 1993; 182: 97–105.
   PubMed Web of Science ®Google Scholar
• Turchany JM, Aley SB, Gillin FD. Giardicidal activity of lactoferrin and N-terminal peptides. Infect Immun 1995; 63: 4550–2.
   PubMed Web of Science ®Google Scholar
• Isamida T, Tanaka T, Omata Y, Yamauchi K, Shimazaki K, Saito A. Protective effect of lactoferricin against Toxoplasma gondii infection in mice. J Vet Med Sci 1998; 60: 241–4.
   PubMed Web of Science ®Google Scholar
• Andersen JH, Gutteberg TJ. Lactoferrin and lactoferricin inhibits HSV-1 and HSV-2 antigen expression in clinical isolates. ICAAC, San Francisco, CA, 1999: Poster.
   Google Scholar
• Groisman EA. How bacteria resist killing by host-defense peptides. Trends Microbiol 1994; 2: 444–9.
   PubMedGoogle Scholar
• Martinez DT, Pizarro-Cerda J, Moreno E, Moriyon I. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun 1995; 63: 30 54–61.
   Google Scholar
• Elass-Rochard E, Roseanu A, Legrand D, et al. Lactoferrin-lipopolysaccharide interaction: involvement of the 28–34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J 1995; 312: 839–45.
   Google Scholar
• Kang JH, Lee MK, Kim KL, Hahm KS. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int J Pept Protein Res 1996; 48: 357–63.
   PubMedGoogle Scholar
• Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, Hayasawa H. N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob Agents Chemother 1999; 43: 1267–9.
   PubMed Web of Science ®Google Scholar
• Williams RW, Starman R, Taylor KM, et al. Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa. Biochemistry 1990; 29: 4490–6.
   PubMed Web of Science ®Google Scholar
• Lee JY, Boman A, Sun CX, et al. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci USA 1989; 86: 9159–62.
   PubMed Web of Science ®Google Scholar
• Rekdal Ø, Andersen J, Vorland LH, Svendsen JS. Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity. J Pept Sci 1999; 5: 32–45.
   Google Scholar
• Vorland LH, Ulvatne H, Andersen J, et al. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998; 30: 513–7.
   PubMed Web of Science ®Google Scholar
• Cociancich S, Ghazi A, Hetru C, Hoffmann JA, Letellier L. Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. J Biol Chem 1993; 268: 19239–45.
   Google Scholar
• Yamauchi K, Tomita M, Giehl TJ, Ellison RT. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993; 61: 719–28.
   PubMed Web of Science ®Google Scholar
• Vorland LH, Ulvatne H, Rekdal O, Svendsen JS. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand J Infect Dis 1999; 31: 467–73.
   PubMed Web of Science ®Google Scholar
• Bellamy WR, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M. Role of cell-binding in the antibacterial mechanism of lactoferricin B. J Appl Bacteriol 1993; 75: 478–84.
   PubMedGoogle Scholar
• Vorland LH, Svendsen JS, Rekdal Ø. Lactoferricin B passes across the cytoplasmic membrane and resides in the cytoplasm [thesis]. Tromsø: University of Tromsø, 1999.
   Google Scholar